ClinicalTrials.Veeva

Menu

Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery

T

Tanta University

Status

Completed

Conditions

Arthroscopic Knee Surgery
Dexmedetomidine
Intra-articular
Lidocaine 5% Patch

Treatments

Drug: Lidocaine 5% patch with Dexmedetomidine Bupivacaine
Drug: Dexmedetomidine Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT04322760
31084/07/16

Details and patient eligibility

About

Surgery of the knee is a very common procedure which can be very painful and sufficient postoperative pain treatment is often problematic. The aim of this work was to study the effects of supplementation of intra-articular bupivacaine dexmedetomidine with lidocaine 5% patch after arthroscopic knee surgery under general anesthesia and its role in improving quality of anesthesia.

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients
  • ASA I & II
  • Aged between 18 to 60 years
  • Weight between 60 to 100 kg
  • Scheduled for elective arthroscopic knee surgery

Exclusion criteria

  • patient refusal.
  • history of cardiac disease.
  • impaired renal or hepatic function.
  • hypertension treated with α methyldopa, clonidine, or beta-adrenergic blockers.
  • if they have used opioid analgesics within the previous 24 hr.
  • previous sensitivity to local anesthetics.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Group A (control group)
Active Comparator group
Description:
Patients in each received 10 ml 0.5 % bupivacaine and 1µg/kg dexmedetomidine diluted in 10 ml saline injected intra-articularly without lidocaine patch
Treatment:
Drug: Dexmedetomidine Bupivacaine
Group B
Experimental group
Description:
Patients in each received 10 ml 0.5 % bupivacaine and 1µg/kg dexmedetomidine diluted in 10 ml saline injected intra-articularly with a patch of lidocaine 5% was applied to the skin
Treatment:
Drug: Lidocaine 5% patch with Dexmedetomidine Bupivacaine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems